Free Trial
→ Elon Musk’s next move from the Oval Office? (From Weiss Ratings) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
JTC
JEMTEC
C$0.90
+4.7%		C$0.86
C$0.62
▼
C$1.00
C$2.51M0.385,351 shs502 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover
20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
JTC
JEMTEC
0.00%0.00%0.00%+3.61%+36.51%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
JTC
JEMTEC
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
JTC
JEMTEC
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
JTC
JEMTEC
C$1.59M1.58C$0.50 per share1.80C$0.84 per share1.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
JTC
JEMTEC
N/AC$0.0245.00∞N/A2.74%1.87%2.06%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A
JTC
JEMTEC
N/A7.14%N/AN/AN/A

Latest ANII, JTC, FGT, and ATT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/3/2025
JTC
JEMTEC
specialC$0.054/11/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ATT
Abattis Bioceuticals
N/AN/AN/A
JTC
JEMTEC
0.40
11.95
14.45

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A
JTC
JEMTEC
N/A

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
JTC
JEMTEC
50.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable
JTC
JEMTEC
N/A2.79 millionN/ANot Optionable

Recent News About These Companies

JEMTEC Inc. Announces Special Dividend Amid Strong Financial Outlook
April 3, 2025 | tipranks.com
JEMTEC 2023 Q1 & FINANCIAL UPDATE
December 14, 2022 | technews.tmcnet.com

Media Sentiment Over Time

Top Headlines

View All Headlines

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

JEMTEC CVE:JTC

C$0.90 +0.04 (+4.65%)
As of 03:35 PM Eastern

JEMTEC Inc. provides integrated technology systems for community-based corrections in Canada. It offers services and technologies for offender monitoring in Canadian federal and provincial correctional departments. The company also provides various levels of technology, which allows corrections, courts, and police to select from various options ensuring the correct level of offender control. n addition, its offender location detection/verification technologies include offender reporting through telephone contact, offender reporting kiosks with integrated database, global positioning system active and passive tracking, voice verification, electronic monitoring house arrest systems, remote alcohol in-home monitoring, and private monitoring services. JEMTEC Inc. was incorporated in 1981 and is headquartered in North Vancouver, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas